Why Long-Term Care Insurance Falls Short for So Many
The private insurance market has proved wildly inadequate in providing financial security for millions of older Americans, in part by underestimating how many policyholders would use their coverage.
Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments
The top 12 states using antibody therapies produced by Regeneron and Lilly — which research shows don’t work against the omicron variant — include several Southern states with some of the nation’s lowest vaccination rates, but also California, which ranks among the top 20 for fully vaccinated residents.
Success of Covid Antiviral Pills Hinges on Access to Speedy and Accurate Tests
The promising antiviral drugs to treat covid can halt hospitalizations and deaths, but only if they’re given to patients within three to five days of their first symptoms, a narrow window many people won’t meet. Here’s why.
Nursing Home Residents Overlooked in Scramble for Covid Antibody Treatments
A federal allocation plan meant to ensure equitable distribution of powerful monoclonal antibody treatments for high-risk patients fails to prioritize nursing home residents, a population that remains particularly vulnerable even after vaccination.
Organ Centers to Transplant Patients: Get a Covid Shot or Move Down on Waitlist
At issue is whether transplant patients who refuse the shots are not only putting themselves at greater risk for serious illness and death from covid-19, but also squandering scarce organs that could benefit others.
A Daily Pill to Treat Covid Could Be Just Months Away, Scientists Say
At least three promising antiviral treatments for covid-19 are being tested in clinical trials, with results expected as soon as late fall or winter.
Científicos dicen que una píldora diaria para tratar covid estaría a meses de distancia
Los medicamentos que se están investigando tendrían el potencial de interferir con la capacidad del virus para replicarse en las células humanas.
Congress Cites KHN Investigation in Probe of National Academies
The House oversight committee is requesting conflict-of-interest disclosure forms from a National Academies committee studying organ transplants. KHN previously reported on apparent conflicts among members of a committee studying drug waste.
‘My Time to Live’: Through Novel Program, Kidney Patients Get Palliative Care, Dialysis ’Til the End
Seattle’s Northwest Kidney Centers, which pioneered kidney failure treatment 50 years ago, now pairs dying patients with hospice services, without forcing them to forgo the comfort dialysis can provide.
These Governors Push Antibody Therapy — But Shun Vaccine and Mask Mandates
Governors in Southern states, amid a surge of delta-variant infections, are rushing to provide an experimental antibody cocktail therapy, even as they oppose measures like mask mandates and vaccine passports that health officials say can prevent infection in the first place.